DK3474902T3 - Farmaceutisk sammensætning der omfatter fluor-18-mærkede gasser - Google Patents
Farmaceutisk sammensætning der omfatter fluor-18-mærkede gasser Download PDFInfo
- Publication number
- DK3474902T3 DK3474902T3 DK17733822.5T DK17733822T DK3474902T3 DK 3474902 T3 DK3474902 T3 DK 3474902T3 DK 17733822 T DK17733822 T DK 17733822T DK 3474902 T3 DK3474902 T3 DK 3474902T3
- Authority
- DK
- Denmark
- Prior art keywords
- fluor
- pharmaceutical composition
- composition including
- labeled
- gases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1206—Administration of radioactive gases, aerosols or breath tests
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/025—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus inorganic Tc complexes or compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Optics & Photonics (AREA)
- Veterinary Medicine (AREA)
- Atmospheric Sciences (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16382304 | 2016-06-28 | ||
| PCT/EP2017/065900 WO2018002079A1 (en) | 2016-06-28 | 2017-06-27 | Pharmaceutical composition comprising fluorine-18 labelled gases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3474902T3 true DK3474902T3 (da) | 2021-11-01 |
Family
ID=56345071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17733822.5T DK3474902T3 (da) | 2016-06-28 | 2017-06-27 | Farmaceutisk sammensætning der omfatter fluor-18-mærkede gasser |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10849994B2 (da) |
| EP (1) | EP3474902B1 (da) |
| DK (1) | DK3474902T3 (da) |
| ES (1) | ES2899296T3 (da) |
| PT (1) | PT3474902T (da) |
| WO (1) | WO2018002079A1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111574316A (zh) * | 2020-04-28 | 2020-08-25 | 新华锦集团有限公司 | 用于制造ri标记化合物的制造方法及制造装置 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE430368T1 (de) * | 2000-02-23 | 2009-05-15 | Univ Alberta The University Of | Verfahren und vorrichtung zur erzeugung von 18f- fluorid |
| DE102005026253A1 (de) * | 2004-06-18 | 2006-01-05 | General Electric Co. | Erzeugung von 18F(F2) Fluor aus 18O(O2) Sauerstoff mit hoher Ausbeute |
| US8231855B2 (en) * | 2010-12-28 | 2012-07-31 | Omotowa Bamidele A | Method for production of sulfur hexafluoride from sulfur tetrafluoride |
-
2017
- 2017-06-27 US US16/310,723 patent/US10849994B2/en active Active
- 2017-06-27 PT PT177338225T patent/PT3474902T/pt unknown
- 2017-06-27 ES ES17733822T patent/ES2899296T3/es active Active
- 2017-06-27 EP EP17733822.5A patent/EP3474902B1/en active Active
- 2017-06-27 WO PCT/EP2017/065900 patent/WO2018002079A1/en unknown
- 2017-06-27 DK DK17733822.5T patent/DK3474902T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2899296T3 (es) | 2022-03-10 |
| WO2018002079A1 (en) | 2018-01-04 |
| EP3474902B1 (en) | 2021-08-11 |
| PT3474902T (pt) | 2021-11-11 |
| US20190262482A1 (en) | 2019-08-29 |
| EP3474902A1 (en) | 2019-05-01 |
| US10849994B2 (en) | 2020-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1243650A1 (zh) | 包含美洛昔康的藥物組合物 | |
| DK3529248T3 (da) | Farmaceutiske sammensætninger | |
| DK3236943T3 (da) | Sammensætninger til ileo-jejunal lægemiddeladministration | |
| DK3089741T3 (da) | Farmaceutiske sammensætninger omfattende azd9291 | |
| DK3253382T3 (da) | Farmaceutiske sammensætninger til kombinationsterapi | |
| BR112016023628A2 (pt) | composições farmacêuticas. | |
| LT3655038T (lt) | Farmacinė kompozicija | |
| EP3454899C0 (en) | PHARMACEUTICAL COMPOSITION | |
| BR112018000054A2 (pt) | composições farmacêuticas liofilizadas | |
| DK3634468T3 (da) | Fast sammensætning til oral indgivelse | |
| DK3554534T3 (da) | Farmaceutisk sammensætning omfattende insulin | |
| DK3529240T3 (da) | Farmaceutiske forbindelser | |
| DK3463345T3 (da) | Farmaceutiske kombinationer | |
| DK3583943T3 (da) | Farmaceutisk sammensætning | |
| DK3199175T3 (da) | Farmaceutisk sammensætning til injektion | |
| DK3278801T3 (da) | Farmaceutisk sammensætning indeholdende mirabegron | |
| DK3191085T3 (da) | Misbrugsresistente farmaceutiske sammensætninger | |
| DK3388085T3 (da) | Farmaceutisk sammensætning og anvendelser deraf | |
| DK3389633T3 (da) | Farmaceutiske sammensætninger, der omfatter phenylaminopyrimidinderivat | |
| PL3207149T3 (pl) | Kompozycja farmaceutyczna o zwiększonej stabilności | |
| DK3313370T3 (da) | Oftalmologisk farmaceutisk sammensætning | |
| DK3280447T3 (da) | Farmaceutiske formuleringer | |
| BR112016030507A2 (pt) | Compostos relacionados à vitamina d, composição farmacêutica, e kit | |
| EP3727485C0 (en) | PHARMACEUTICAL COMPOSITION | |
| SMT202400478T1 (it) | Composizione farmaceutica |